Off-pump cardiac surgery abolishes complement activation

Background . This prospective randomized study compared the inflammatory response in patients undergoing elective on-pump and off-pump coronary artery bypass grafting. Patients and methods. Forty-four patients undergoing elective coronary artery bypass grafting were recruited with 22 patients randomized to on-pump heart surgery and 22 patients to off-pump coronary bypass surgery. Plasma levels of C3bc, the terminal SC5b-9 complement complex, myeloperoxidase, β -thromboglobulin and prothrombin fragment F1 + 2 were measured before the operation, intraoperatively, at termination of the operation, and two hours post-operatively. Results. Complement was markedly activated in the on-pump group as indicated by a significant increase in C3bc and SC5b-9 (p < 0.001 for both), whereas no complement activation was seen in the off-pump group (p = 0.001 between the groups). In contrast, both groups showed significant activation of neutrophils, platelets and coagulation, as indicated by an early increase in myeloperoxidase and a post-operative increase in β-thromboglobulin and F1 + 2, respectively. Notably, there were no inter-group differences with regard to neutrophil and platelet activation, whereas coagulation activation was more pronounced in the off-pump group (p < 0.01). Conclusions. Off-pump surgery completely eliminated the heart-lung machine-induced complement activation. Neutrophils and platelets were equally activated in both groups, whereas coagulation was enhanced post-operatively in the off-pump group. Perfusion (2007) 22, 251—256.

[1]  P. Venge,et al.  Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. , 2008, Artificial organs.

[2]  E. Fosse,et al.  Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials. , 2008, Clinical and experimental immunology.

[3]  M. Mack,et al.  Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes , 2005, Circulation.

[4]  N. Doll,et al.  Impact of off-pump coronary bypass grafting on the prevalence of adverse perioperative outcome in women undergoing coronary artery bypass grafting surgery. , 2005, The Annals of thoracic surgery.

[5]  G. Grunkemeier,et al.  Outcomes after usage of a quality initiative program for off-pump coronary artery bypass surgery: a comparison with on-pump surgery. , 2004, The Annals of thoracic surgery.

[6]  G. Murphy,et al.  Side Effects of Cardiopulmonary Bypass: , 2004, Journal of cardiac surgery.

[7]  T. Carrel,et al.  Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results. , 2004, The Annals of thoracic surgery.

[8]  C. Hogue,et al.  Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. , 2001, The Annals of thoracic surgery.

[9]  M. Galiñanes,et al.  Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. , 2000, The Annals of thoracic surgery.

[10]  V. Videm,et al.  Platelet Compatibility of an Artificial Surface Modified with Functionally Active Heparin , 1999, Thrombosis and Haemostasis.

[11]  W. van Oeveren,et al.  Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? , 1999, The Annals of thoracic surgery.

[12]  E. Fosse,et al.  Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo. , 1999, The Journal of thoracic and cardiovascular surgery.

[13]  W. van Oeveren,et al.  Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. , 1998, The Annals of thoracic surgery.

[14]  E. Fosse,et al.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[15]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[16]  T. Lea,et al.  Quantification in Enzyme‐Linked Immunosorbent Assay of a C3 Neoepitope Expressed on Activated Human Complement Factor C3 , 1988, Scandinavian journal of immunology.

[17]  E. Fosse,et al.  Complement activation during major operations with or without cardiopulmonary bypass. , 1987, The Journal of thoracic and cardiovascular surgery.

[18]  S. Frøland,et al.  Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex , 1985, Scandinavian journal of immunology.

[19]  T. Lea,et al.  Detection and Quantification of the Terminal C5b‐9 Complex of Human Complement by a Sensitive Enzyme‐Linked Immunosorbent Assay , 1984, Scandinavian journal of immunology.

[20]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, The Journal of thoracic and cardiovascular surgery.

[21]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[22]  M. Caputo,et al.  Off-pump coronary artery bypass grafting: not a flash in the pan. , 2003, The Annals of thoracic surgery.

[23]  T. Evans,et al.  Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  T. Hugli,et al.  Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. , 1984, Analytical biochemistry.